Abstract
3-hydroxyisobutyric aciduria is an organic aciduria with a poorly understood biochemical basis. It has previously been assumed that deficiency of 3-hydroxyisobutyrate dehydrogenase (HIBADH) in the valine catabolic pathway is the underlying enzyme defect, but more recent evidence makes it likely that individuals with 3-hydroxyisobutyryic aciduria represent a heterogeneous group with different underlying mechanisms, including respiratory chain defects or deficiency of methylmalonate semialdehyde dehydrogenase. However, to date methylmalonate semialdehyde dehydrogenase deficiency has only been demonstrated at the gene level for a single individual. We present two unrelated patients who presented with developmental delay and increased urinary concentrations of 3-hydroxyisobutyric acid. Both children were products of consanguineous unions and were of European or Pakistani descent. One patient developed a febrile illness and subsequently died from a hepatoencephalopathy at 2 years of age. Further studies were initiated and included tests of the HIBADH enzyme in fibroblast homogenates, which yielded normal activities. Sequencing of the ALDH6A1 gene (encoding methylmalonate semialdehyde dehydrogenase) suggested homozygosity for the missense mutation c.785 C > A (S262Y) in exon 7 which was not found in 210 control alleles. Mutation analysis of the ALDH6A1 gene of the second patient confirmed the presence of a different missense mutation, c.184 C > T (P62S), which was also identified in 1/530 control chromosomes. Both mutations affect highly evolutionarily conserved amino acids of the methylmalonate semialdehyde dehydrogenase protein. Mutation analysis in the ALDH6A1 gene can reveal a cause of 3-hydroxyisobutyric aciduria, which may present with only slightly increased urinary levels of 3-hydroxyisobutyric acid, if a patient is metabolically stable.
Similar content being viewed by others
References
Barber JC, Maloney V, Hollox EJ, Stuke-Sontheimer A, du Bois G, Daumiller E, Klein-Vogler U, Dufke A, Armour JA, Liehr T (2005) Duplications and copy number variants of 8p23.1 are cytogenetically indistinguishable but distinct at the molecular level. Eur J Hum Genet 13:1131–1136
Bennett MJ, Sherwood WG, Gibson KM, Burlina AB (1993) Secondary inhibition of multiple NAD-requiring dehydrogenases in respiratory chain complex I deficiency: possible metabolic markers for the primary defect. J Inherit Metab Dis 16:560–562
Boulat O, Benador N, Giraradin E, Bachmann C (1995) 3-Hydroxyisobutyryic aciduria with a mild clinical course. J Inherit Metab Dis 18:204–206
Brewster M, Goodman S, Rhead W, Brown G, Collie W, Bornhofen J (1991) Valine-related 3-hydroxyisobutyryic aciduria in twins. Proccedings of the Society for Inherited Metabolic Disorders 1991 (abstract)
Chambliss KL, Gray RG, Rylance G, Pollitt RJ, Gibson KM (2000) Molecular characterization of methylmalonate semialdehyde dehydrogenase deficiency. J Inherit Metab Dis 23:497–504
Chitayat D, Meagher-Villemure K, Mamer OA, O’Gorman A, Hoar DI, Silver K, Scriver CR (1992) Brain dysgenesis and congenital intracerebral calcification associated with 3-hydroxyisobutyric aciduria. J Pediatr 121:86–89
Congdon PJ, Haigh D, Smith R, Green A, Pollitt RJ (1981) Hypermethioninaemia and 3-hydroxyisobutyric aciduria in an apparently healthy baby. J Inherit Metab Dis 4:79–80
Gibson KM, Lee CF, Bennett MJ, Holmes B, Nyhan WL (1993) Combined malonic, methylmalonic and ethylmalonic acid semialdehyde dehydrogenase deficiencies: an inborn error of beta-alanine, L-valine and L-alloisoleucine metabolism? J Inherit Metab Dis 16:563–568
Gray RG, Pollitt RJ, Webley J (1987) Methylmalonic semialdehyde dehydrogenase deficiency: demonstration of defective valine and beta-alanine metabolism and reduced malonic semialdehyde dehydrogenase activity in cultured fibroblasts. Biochem Med Metab Biol 38:121–124
Ko FJ, Nyhan WL, Wolf J, Barshop B, Sweetman L (1991) 3-Hydroxyisobutyric aciduria: an inborn error of valine metabolism. Pediatr Res 30:322–326
Lai MW, Klein-Schwartz W, Rodgers GC, Abrams JY, Haber DA, Bronstein AC, Wruk KM (2006) 2005 Annual Report of the American Association of Poison Control Centers' national poisoning and exposure database. Clin Toxicol (Phila) 44:803–932
Loupatty FJ, van der Steen A, Ijlst L, Ruiter JP, Ofman R, Baumgartner MR, Ballhausen D, Yamaguchi S, Duran M, Wanders RJ (2006) Clinical, biochemical, and molecular findings in three patients with 3-hydroxyisobutyric aciduria. Mol Genet Metab 87:243–248
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275
Mienie LJ, Erasmus E (1990) Biochemical studies on a patient with a possible 3-hydroxyisobutyrate dehydrogenase deficiency. Fifth International Congress on Inborn Errors of Metabolism 1990 (abstract)
Pollitt RJ, Green A, Smith R (1985) Excessive excretion of beta-alanine and of 3-hydroxypropionic, R- and S-3-aminoisobutyric, R- and S-3-hydroxyisobutyric and S-2-(hydroxymethyl)butyric acids probably due to a defect in the metabolism of the corresponding malonic semialdehydes. J Inherit Metab Dis 8:75–79
Sasaki M, Kimura M, Sugai K, Hashimoto T, Yamaguchi S (1998) 3-Hydroxyisobutyric aciduria in two brothers. Pediatr Neurol 18:253–255
Sasaki M, Iwata H, Sugai K, Fukumizu M, Rimura M, Yamaguchi S (2001) A severely brain-damaged case of 3-hydroxyisobutyryic aciduria. Brain Dev 23:243–245
Schwarz JM, Rödelsperger C, Schuelke M, Seelow D (2010) MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods 7:575–576
Shield JP, Gough R, Allen J, Newbury-Ecob R (2001) 3-Hydroxyisobutyric aciduria: phenotypic heterogeneity within a single family. Clin Dysmorphol 10:189–191
Song X, Anderson V, Guzman M, Rao C (2009) Neuropathology of 3-hydroxyisobutyric aciduria, an autopsy case report. Can J Neurol Sci 36:483–486
Tsai CH, Graw SL, McGavran L (2002) 8p23 duplication reconsidered: is it a true euchromatic variant with no clinical manifestation? J Med Genet 39:769–774
Vasiliou V, Pappa A (2000) Polymorphisms of human aldehyde dehydrogenases. Consequences for drug metabolism and disease. Pharmacology 61:192–198
Wanders RJA, Duran M, Loupatty FJ (2010) Enzymology of the branched-chain amino acid oxidation disorders: the valine pathway. J Inherit Metab Dis. doi:10.1007/s10545-010-9236-x
Acknowledgements
The authors thank S. Henger, C. König, S. Rosenfelder, and D. Gunzlé for excellent technical assistance. JOS is grateful to the Jürgen Manchot Stiftung (Düsseldorf, Germany) and the Wissenschaftliche Gesellschaft in Freiburg im Breisgau (Germany) for financial support. The content of the article has not been influenced by the sponsors.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by: K. Michael Gibson
Competing interest: None declared.
Rights and permissions
About this article
Cite this article
Sass, J.O., Walter, M., Shield, J.P.H. et al. 3-Hydroxyisobutyrate aciduria and mutations in the ALDH6A1 gene coding for methylmalonate semialdehyde dehydrogenase. J Inherit Metab Dis 35, 437–442 (2012). https://doi.org/10.1007/s10545-011-9381-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-011-9381-x